Population aging is a global phenomenon, and while not as critical as finding cures for cancer or rare diseases, anti-aging therapies – a branch of regenerative medicine – have consistently intrigued researchers, investors, and biotech entrepreneurs for the last decade.

The word ‘protein’ often makes one think of a steak dinner or a smoothie, but in the world of biotech protein therapeutics are forming the backbone of next-generation therapies and novel medicines…